of
Hope
Download the latest issue of Lymphoma Today
Updates on Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches
On Thursday, July 24, 2008 from 1:30pm – 2:30pm ET, the Lymphoma Research Foundation (LRF), the CLL Information Group and CancerCare brought together a distinguished panel of researchers and clinicians for a lymphoma teleconference entitled Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches.
This program is made possible by an unrestricted educational grant to LRF from Cephalon Oncology.
To listen to a free recording of this teleconference via the web, please click here.
To listen to a free recording of this teleconference by telephone, please call 888-333-7533.
Program Faculty
Richard R. Furman, MD
Director, CLL Research Center, Weill Cornell Medical College
New York Presbyterian Hospital
Clive S. Zent, MD
Consultant Hematologist, Associate Professor of Medicine, Mayo Clinic
Brian Tomlinson, MPA, BSW
Director, Patient Education, Lymphoma Research Foundation
John Balan
Founder, CLL Information Group
Richard Dickens, MSW
Blood Cancers Program Coordinator, Project Coordinator, Mind/Body Program
CancerCare
Topics Discussed
- Complications
- Overview of Clinical Trials
- New Treatment Approaches
- Questions for Our Panel of Experts
Presented in Collaboration With
- CLL Information Group (CIG)
- CancerCare
- American Cancer Society
- American Pain Foundation
- American Society of Clinical Oncology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Women's Health Imperative
- Cancer Patient Education Network
- Education Network to Advance Cancer Clinical Trials
- Intercultural Cancer Council
- Multinational Association of Supportive Care in Cancer
- National Center for Frontier Communities
- National Coalition for Cancer Survivorship
- Pathways to Prevention
- Research Advocacy Network
- The Wellness Community
